Toll Brothers (NYSE:TOL – Get Free Report) had its price target dropped by equities research analysts at UBS Group from $185.00 to $183.00 in a report issued on Thursday,Benzinga reports. The ...
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” ...
Kepler Capital analyst Pablo Cuadrado maintained a Buy rating on Repsol (0NQG – Research Report) on February 20 and set a price target of ...
In a report released on February 20, Pablo Cuadrado from Kepler Capital maintained a Buy rating on Neste Corporation (0O46 – Research Report), ...
The latest Market Talks covering Energy and Utilities. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and ...
RBC Capital analyst Mike Dahl maintained an Outperform rating and raised the price target from $213 to $217 on Nov. 7, 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results